본문 바로가기

Comorbidity index for predicting mortality at 6 months after reperfusion therapy

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
SCIENTIFIC REPORTS11(1) · 2021
피인용
Web of Science 10Scopus 9
FWCI (Scopus)
0.31
JCR IF
JCR 2020 4.38
ISSN
2045-2322

저자

  1. Nam, Hyo Suk제1저자Department of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
  2. Kim, Young DaeDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
  3. Yoo, JoonsangDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
  4. Park, HyungjongDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
  5. Kim, Byung MoonDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea
  6. Bang, Oh YoungDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  7. Kim, Hyeon ChangDepartment of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
  8. Han, EunaCollege of Pharmacy, Yonsei Institute for Pharmaceutical Research, Yonsei University, Incheon, South Korea
  9. Kim, Dong JoonDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea
  10. Heo, JoonyungDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
  11. Kim, MinyoungDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
  12. Choi, Jin KyoDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
  13. Lee, Kyung-YulDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Korea
  14. Lee, Hye SunDepartment of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea
  15. Shin, Dong HoonDepartment of Neurology, Gachon University Gil Medical Center, Incheon, Korea
  16. Choi, Hye-YeonDepartment of Neurology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea
  17. Sohn, Sung-IlDepartment of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea
  18. Hong, Jeong-HoDepartment of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea
  19. Lee, Jong YunDepartment of Neurology, National Medical Center, Seoul, Korea
  20. Baek, Jang-HyunDepartment of Neurology, National Medical Center, Seoul, Korea
  21. Kim, Gyu SikDepartment of Neurology, National Health Insurance Service Ilsan Hospital, Ilsan, Korea
  22. Seo, Woo-KeunDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  23. Chung, Jong-WonDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  24. Kim, Seo HyunDepartment of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea
  25. Song, Tae-JinDepartment of Neurology, College of Medicine, Ewha Woman’s University, Seoul, Korea
  26. Han, Sang WonDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
  27. Park, Joong HyunDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
  28. Kim, JinkwonDepartment of Neurology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
  29. Jung, Yo HanDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Korea
  30. 조한진Department of Neurology, Pusan National University School of Medicine, Busan, Korea
저자 34명 모두 보기

초록

The eligibility of reperfusion therapy has been expanded to increase the number of patients. However, it remains unclear the reperfusion therapy will be beneficial in stroke patients with various comorbidities. We developed a reperfusion comorbidity index for predicting 6-month mortality in patients with acute stroke receiving reperfusion therapy. The 19 comorbidities included in the Charlson comorbidity index were adopted and modified. We developed a statistical model and it was validated using data from a prospective cohort. Among 1026 patients in the retrospective nationwide reperfusion therapy registry, 845 (82.3%) had at least one comorbidity. As the number of comorbidities increased, the likelihood of mortality within 6 months also increased (p<0.001). Six out of the 19 comorbidities were included for developing the reperfusion comorbidity index on the basis of the odds ratios in the multivariate logistic regression analysis. This index showed good prediction of 6-month mortality in the retrospective cohort (area under the curve [AUC], 0.747; 95% CI, 0.704-0.790) and in 333 patients in the prospective cohort (AUC, 0.784; 95% CI, 0.709-0.859). Consideration of comorbidities might be helpful for the prediction of the 6-month mortality in patients with acute ischemic stroke who receive reperfusion therapy.

식별자

Scopus EID
2-s2.0-85102584295
WoS UID
000630511800009